Published in J Clin Microbiol on March 09, 2011
(1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients. Eur J Clin Microbiol Infect Dis (2014) 0.95
Prevalence and genotype distribution of Pneumocystis jirovecii in Cuban infants and toddlers with whooping cough. J Clin Microbiol (2013) 0.85
Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia. Emerg Infect Dis (2013) 0.85
Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii. J Clin Microbiol (2014) 0.83
Trimethoprim resistance of dihydrofolate reductase variants from clinical isolates of Pneumocystis jirovecii. Antimicrob Agents Chemother (2013) 0.83
New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards. PLoS One (2015) 0.80
Pneumocystis jirovecii--from a commensal to pathogen: clinical and diagnostic review. Parasitol Res (2015) 0.77
Diversity of Pneumocystis jirovecii during Infection Revealed by Ultra-Deep Pyrosequencing. Front Microbiol (2016) 0.77
Prevalence of colonization and mitochondrial large subunit rRNA mutation of Pneumocystis jiroveci among Iranian children. Iran J Microbiol (2016) 0.75
A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science (2006) 15.18
Structure of ribosomal RNA. Annu Rev Biochem (1984) 9.44
Structure, dynamics, and catalytic function of dihydrofolate reductase. Annu Rev Biophys Biomol Struct (2004) 3.42
Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. Genome Res (1997) 2.90
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet (1999) 2.80
Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res (2000) 2.79
Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis (2004) 2.70
SNP genotyping: technologies and biomedical applications. Annu Rev Biomed Eng (2007) 2.52
Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol (1990) 2.42
Multiplex polymerase chain reaction: a practical approach. J Clin Lab Anal (2002) 2.42
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08
Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci U S A (1999) 1.97
Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J Infect Dis (1999) 1.79
SBE-TAGS: an array-based method for efficient single-nucleotide polymorphism genotyping. Proc Natl Acad Sci U S A (2000) 1.74
Pre-AIDS era isolates of Pneumocystis carinii f. sp. hominis: high genotype similarity with contemporary isolates. J Clin Microbiol (1998) 1.40
Single-nucleotide polymorphism phylotyping of Escherichia coli. Appl Environ Microbiol (2005) 1.36
Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS (2005) 1.32
Pneumocystis jiroveci genotypes in the Spanish population. Clin Infect Dis (2004) 1.27
Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob Agents Chemother (2004) 1.21
Multiplexed, high-throughput genotyping by single-base extension and end-labeled free-solution electrophoresis. Anal Chem (2002) 1.21
Genetic diversity of Pneumocystis carinii in HIV-positive and -negative patients as revealed by PCR-SSCP typing. AIDS (2001) 1.16
Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics. Womens Health Issues (2006) 1.05
Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients. Infect Genet Evol (2010) 0.94
Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin Microbiol Infect (2008) 0.92
Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. Clin Infect Dis (2010) 0.92
Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations. Parasite (2010) 0.92
Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal. J Antimicrob Chemother (2006) 0.91
Genotypic variation in Pneumocystis jirovecii isolates in Britain. Thorax (2005) 0.91
Prophylaxis failure is associated with a specific Pneumocystis carinii genotype. Clin Infect Dis (2001) 0.91
Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections. Eur J Clin Microbiol Infect Dis (2001) 0.90
Pneumocystis jirovecii multilocus gene sequencing: findings and implications. Future Microbiol (2010) 0.87
Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data. Clin Microbiol Infect (2009) 0.84
Isolates of Pneumocystis jirovecii from Harare show high genotypic similarity to isolates from London at the superoxide dismutase locus. Trans R Soc Trop Med Hyg (2005) 0.80
Detection of Pneumocystis jirovecii dihydropteroate synthase polymorphisms in patients with Pneumocystis pneumonia. Scand J Infect Dis (2005) 0.79
Multilocus genotyping of Pneumocystis jirovecii in immunocompromised patients: preliminary results. J Eukaryot Microbiol (2006) 0.77
Multiplex PCR-single-base extension genotyping of multiple glutathione S-transferase polymorphisms. Biotechnol Appl Biochem (2005) 0.77
Molecular cloning and characterization of a superoxide dismutase (sod) gene in Pneumocystis carinii. J Eukaryot Microbiol (1998) 0.77
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS (2002) 2.90
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med (2000) 2.49
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood (2001) 2.37
Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med (1987) 2.32
AIDS across Europe, 1994-98: the EuroSIDA study. Lancet (2000) 2.13
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol (1998) 2.11
A comparison of Cryptosporidium subgenotypes from several geographic regions. J Eukaryot Microbiol (2001) 1.86
Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development. Circ Res (2001) 1.81
Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha. Ann Rheum Dis (2003) 1.74
Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.43
Physical excercise and thrombotic risk in the elderly. Rev Port Cardiol (2001) 1.37
Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy. J Clin Microbiol (2000) 1.35
Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J Med Virol (2000) 1.32
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study. Ann Intern Med (1999) 1.30
Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol (1998) 1.29
ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-kappa B to regulate the inducible nitric-oxide synthase gene. J Biol Chem (2000) 1.24
Decreased cellular permeability to H2O2 protects Saccharomyces cerevisiae cells in stationary phase against oxidative stress. FEBS Lett (2004) 1.09
Multilocus genotyping of Cryptosporidium isolates from human HIV-infected and animal hosts. J Eukaryot Microbiol (2001) 1.04
Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells. Leukemia (2011) 1.04
Six new isolates of human immunodeficiency virus type 2 (HIV-2) and the molecular characterization of one (HIV-2CAM2). J Gen Virol (1989) 1.01
Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease. Circulation (1983) 1.01
PCR-RFLP analysis of Cryptosporidium parvum isolates from HIV-infected patients in Lisbon, Portugal. Ann Trop Med Parasitol (2000) 0.97
Multilocus PCR-RFLP analysis of Cryptosporidium isolates from HIV-infected patients from Portugal. Ann Trop Med Parasitol (2001) 0.97
Evidence of Nef truncation in human immunodeficiency virus type 2 infection. J Infect Dis (1998) 0.97
Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension. Eur Respir J (2011) 0.96
(1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients. Eur J Clin Microbiol Infect Dis (2014) 0.95
Interplay between apoptosis and autophagy, a challenging puzzle: new perspectives on antitumor chemotherapies. Chem Biol Interact (2013) 0.94
Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection. J Immunol (1999) 0.93
Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections. J Acquir Immune Defic Syndr (2000) 0.93
Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin Microbiol Infect (2008) 0.92
A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study Group. AIDS (1994) 0.92
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients. AIDS (2001) 0.91
Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery. Clin Exp Immunol (1999) 0.91
Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections. Eur J Clin Microbiol Infect Dis (2001) 0.90
Coreceptor usage by HIV-1 and HIV-2 primary isolates: the relevance of CCR8 chemokine receptor as an alternative coreceptor. Virology (2010) 0.90
Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay. J Clin Microbiol (1999) 0.90
Prevalence of cryptosporidiosis in AIDS patients with diarrhoea in Santa Maria Hospital, Lisbon. Folia Parasitol (Praha) (1998) 0.89
Occurrence of Cryptosporidium and Giardia genotypes and subtypes in raw and treated water in Portugal. Lett Appl Microbiol (2009) 0.89
Mutations in the dihydropteroate synthase gene of Pneumocystis jiroveci isolates from Portuguese patients with Pneumocystis pneumonia. Int J Antimicrob Agents (2003) 0.88
Role of glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase in the reduction of lysophospholipid hydroperoxides. Free Radic Biol Med (1997) 0.86
HIV/Leishmania co-infections in Portugal: diagnosis and isoenzyme characterization of Leishmania. Ann Trop Med Parasitol (1997) 0.86
Serologic diagnosis of toxoplasmosis in experimentally infected pregnant goats and transplacentally infected kids. Am J Vet Res (1985) 0.86
Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999. HIV Med (2008) 0.85
Influence of age on rates of new AIDS-defining diseases and survival in 6546 AIDS patients. Scand J Infect Dis (1997) 0.85
Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol (2011) 0.84
Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data. Clin Microbiol Infect (2009) 0.84
Chemical features of flavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents. Chem Biol Interact (2000) 0.83
Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries. J Hosp Infect (2009) 0.82
Phylogenetic analysis of HIV type 2 strains from Portugal. AIDS Res Hum Retroviruses (1998) 0.82
Methodology of the diagnosis of microsporidiosis in urine and pulmonary specimens from AIDS patients. J Eukaryot Microbiol (2001) 0.82
The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats. Thromb Res (1999) 0.81
[Brucellosis]. Acta Med Port (1999) 0.80
Attenuation of coronary vascular resistance by selective alpha 1-adrenergic blockade in patients with coronary artery disease. J Am Coll Cardiol (1985) 0.80
Genotoxicity of instant coffee: possible involvement of phenolic compounds. Mutat Res (1999) 0.80
Analysis of the pathways of nitric oxide utilization in mitochondria. Free Radic Res (2000) 0.80
DNA-lipid systems. A physical chemistry study. Braz J Med Biol Res (2002) 0.80
Metabolism of galangin by rat cytochromes P450: relevance to the genotoxicity of galangin. Mutat Res (1997) 0.80
Phasic pressure gradients across coronary and renal artery stenoses in humans. Am Heart J (1983) 0.80
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study Group. AIDS (1998) 0.80
Effects of prostacyclin on coronary hemodynamics at rest and in response to cold pressor testing in patients with angina pectoris. Am J Cardiol (1984) 0.79
The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era. Clin Trials (2006) 0.79
Pneumocystis jirovecii multilocus genotyping in pooled DNA samples: a new approach for clinical and epidemiological studies. Clin Microbiol Infect (2012) 0.79
Detection of Pneumocystis jirovecii dihydropteroate synthase polymorphisms in patients with Pneumocystis pneumonia. Scand J Infect Dis (2005) 0.79
[The no-reflow phenomenon: its incidence and clinical characteristics in a series of cases]. Arch Inst Cardiol Mex (1998) 0.79
Kinetic modelling of in vitro lipid peroxidation experiments--'low level' validation of a model of in vivo lipid peroxidation. Free Radic Res (1995) 0.79
Structural requirements for mutagenicity of flavonoids upon nitrosation. A structure-activity study. Mutagenesis (1995) 0.79
Antioxidant and antibacterial activity of essential oil and extracts of bay laurel Laurus nobilis Linnaeus (Lauraceae) from Portugal. Nat Prod Res (2011) 0.79
Identification and characterization of HIV-2 strains obtained from asymptomatic patients that do not use CCR5 or CXCR4 coreceptors. Virology (2003) 0.78
Population mobility and the changing epidemics of HIV-2 in Portugal. HIV Med (2011) 0.78
Intramedullary tuberculoma in a patient with human immunodeficiency virus infection and disseminated multidrug-resistant tuberculosis: case report. Int J Infect Dis (1998) 0.78
Involvement of rat cytochrome 1A1 in the biotransformation of kaempferol to quercetin: relevance to the genotoxicity of kaempferol. Mutagenesis (1997) 0.78
Mutagenicity of kaempferol in V79 cells: the role of cytochromes P450. Teratog Carcinog Mutagen (1996) 0.78
Genotoxicity of nitrosated red wine and of the nitrosatable phenolic compounds present in wine: tyramine, quercetin and malvidine-3-glucoside. Food Chem Toxicol (1993) 0.77
Multiple cranial neuropathy and HIV-2. J Neurol Neurosurg Psychiatry (2004) 0.77
Medium-term results of 173 ligamentoplasties of the anterior cruciate ligament using the MacIntosh technique reinforced by the Kennedy ligament augmentation device (LAD). Knee Surg Sports Traumatol Arthrosc (1995) 0.77
Smear microscopy to diagnose tuberculosis early and prevent further transmission in a population with a high prevalence of HIV infection. Clin Microbiol Infect (2003) 0.77
Characterization of HIV-2 chimeric viruses unable to use CCR5 and CXCR4 coreceptors. Virus Res (2009) 0.77
Mechanisms of myricetin mutagenicity in V79 cells: involvement of radicalar species. Teratog Carcinog Mutagen (1996) 0.77
Bulk cytokine production versus frequency of cytokine-producing cells in HIV1 infection before and during HAART. Clin Immunol (2000) 0.77
Iatrogenic hallux varus surgical procedure: a study of 14 cases. Foot Ankle Int (1995) 0.77